Find investors
← Back to all investors
NM
ResearchedAngel Investors

Neil Macfadyen

Angel InvestorsSeed Round
Pitch Neil

Get their honest, personalized take on your startup.

Sign in to pitch Neil

At a glance

Full Name
Neil Macfadyen
Title
Investment Director
Firm
Committed Capital (Committed Capital Financial Services Limited)
Firm Type
EIS / growth-stage venture capital fund manager and corporate finance advisory (FCA authorised, FRN 192203) — *note: the stub's "Angel Investors" label understates the firm; Committed Capital is a managed EIS fund and advisory house, though Macfadyen has also personally held director roles across private ventures*
Investment Stage
Growth-stage (post-revenue), EIS-qualifying — *not pure seed; typically companies already generating revenue over ~£1m*
Check Size
Firm typically invests £0.5m–£2m per company
Target Company Profile
Post-revenue (over £1m), EIS-qualifying, growth-stage UK companies with strong technical solutions addressing a substantial market; the firm takes a board seat and provides hands-on operational support
Sector Focus
Technology, with a stated "software only" emphasis (hardware businesses excluded as of 2025); sectors span across the diversified EIS portfolio
Geographic Focus
United Kingdom
Location
London, United Kingdom

Background

Neil Macfadyen (born July 1964, British) is an Investment Director at Committed Capital, the London-based EIS fund manager and corporate finance advisory firm headquartered at 150 Buckingham Palace Road, London SW1W 9TR. His disclosed skill set centres on corporate finance, venture capital, private equity, valuation, restructuring, M&A, due diligence and asset management — the core toolkit of a growth-stage investor who takes board positions in investee companies.

Before Committed Capital, Macfadyen's career spanned institutional asset management and professional services. Public bios list prior roles at M Change, Aberdeen Asset Managers Ltd, Murray Johnstone International and KPMG (US) — a background that combines fund management with audit/advisory experience, consistent with Committed Capital's dual identity as both investor and corporate finance adviser.

His connection to Committed Capital is long-standing and documented in UK company filings: he was appointed a director of Committed Capital Fund Management Limited (Jan 2010), Committed Capital Financial Services Limited (Mar 2010, resigned Dec 2012 as a statutory director) and Committed Capital Syndicate Limited (2011). He continues to operate under a Committed Capital email address as Investment Director. Separately, Companies House records show him active across a range of private ventures over three decades, including hospitality/pub-related companies (e.g., Mercury Taverns, London Bottles, Bond Street Blues) and Ironmoat LLP, reflecting a broad entrepreneurial and directorship history alongside his investing role.

Note: Macfadyen does not currently appear on Committed Capital's public "Team" page (which lists Steve Harris as CEO and Tim Steel as Chairman), so his current day-to-day mandate within the firm should be confirmed directly.

Investment Thesis & Focus

  • Invests as part of Committed Capital's EIS funds into post-revenue, growth-stage UK technology companies — the firm describes targets as having "excellent technical solutions to pressing issues in a substantial addressable market."
  • Check size £0.5m–£2m per company, often across multiple rounds; the Growth EIS Fund builds diversified portfolios of roughly 8–12 companies.
  • "Low volume, high conviction" approach: the firm takes a board seat on all investee companies and commits both financial and human capital, guiding management via advice and introductions.
  • Software-focused as of 2025, having stated it excludes hardware businesses from its strategy.
  • Explicit exit orientation: aims to exit within ~4–5 years via trade sale, IPO or sale to a strategic/financial investor. Track record cited by the firm: ~35 EIS-qualifying investments since 2001, 24 exits (21 profitable), average ~2.6–3x ROI excluding tax relief, ~4.5-year average hold, and £124.3m returned to investors against a £42m base cost.

Notable Investments

  • Healthera — described as "the UK's leading digital pharmacy platform"; Committed Capital led a £2m round in April 2025.
  • Kortext — digital textbook / edtech platform; a Committed Capital portfolio company named a finalist for the EISA Impact Award (2026).

Unlock the full research

Get how to approach them, recent activity, sources, contact links — plus pitch their AI twin for a candid read on your raise.

One-time. Stays unlocked for you.